Unknown

Dataset Information

0

Old and re-purposed drugs for the treatment of COVID-19.


ABSTRACT: Introduction: The coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It has caused a global pandemic with more than three hundred thousand case fatalities. However, apart from supportive care by respirators, no standard medical therapy is validated. Areas covered: This paper presents old drugs with potential in vitro efficacy against SARS-CoV-2. The in vitro database, adverse effects, and potential toxicities of these drugs are reviewed regarding their feasibility of clinical prescription for the treatment of patients with COVID-19. To obtain convincing recommendations, we referred to opinions from the US National Institute of Health regarding drugs repurposed for COVID-19 therapy. Expert opinion: Although strong evidence of well-designed randomized controlled studies regarding COVID-19 therapy is presently lacking, remdesivir, teicoplanin, hydroxychloroquine (not in combination with azithromycin), and ivermectin might be effective antiviral drugs and are deemed promising candidates for controlling SARS-CoV-2. In addition, tocilizumab might be considered as the supplementary treatment for COVID-19 patients with cytokine release syndrome. In future, clinical trials regarding a combination of potentially effective drugs against SARS-CoV-2 need to be conducted to establish the optimal regimen for the treatment of patients with moderate-to-severe COVID-19.

SUBMITTER: Jean SS 

PROVIDER: S-EPMC7441793 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7167223 | biostudies-literature
| S-EPMC8428568 | biostudies-literature
| S-EPMC4920216 | biostudies-literature
| S-EPMC8202634 | biostudies-literature
| S-EPMC7416635 | biostudies-literature
| S-EPMC8856626 | biostudies-literature
| S-EPMC7680713 | biostudies-literature
| S-EPMC9844439 | biostudies-literature
| S-EPMC7324004 | biostudies-literature
| S-EPMC8962306 | biostudies-literature